Finally, data obtained from Fst gene therapy studies in both human and nonhuman primates did not indicate apparent structural or functional aberration in various tissues, suggesting that FST may have therapeutic potential in clinical settings for the treatment of obesity and related diseases. This evidence concerns the gene FST and obesity disorder.